Ruane Cunniff & Goldfarb Has Lowered West Pharmaceutical Svsc (WST) Stake, Usana Health Sciences (USNA) Sentiment Is 8.2

June 19, 2017 - By Peter Erickson

USANA Health Sciences, Inc. develops and makes science nutritional and personal care products. The company has market cap of $1.59 billion. The Firm operates as a direct selling firm in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. It has a 16.34 P/E ratio. The Company’s product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other.

Ruane Cunniff & Goldfarb Inc decreased West Pharmaceutical Svsc Inc (WST) stake by 11.94% reported in 2016Q4 SEC filing. Ruane Cunniff & Goldfarb Inc sold 50,686 shares as West Pharmaceutical Svsc Inc (WST)’s stock rose 14.65%. The Ruane Cunniff & Goldfarb Inc holds 373,781 shares with $31.71M value, down from 424,467 last quarter. West Pharmaceutical Svsc Inc now has $7.04B valuation. The stock rose 0.03% or $0.03 reaching $96. About 132,379 shares traded. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since June 19, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.

About 27,955 shares traded. USANA Health Sciences, Inc. (USNA) has risen 6.87% since June 19, 2016 and is uptrending. It has underperformed by 9.83% the S&P500.

Analysts await USANA Health Sciences, Inc. (NYSE:USNA) to report earnings on July, 25.

Hays Advisory Llc holds 1.09% of its portfolio in USANA Health Sciences, Inc. for 79,510 shares. Capital Impact Advisors Llc owns 22,908 shares or 0.58% of their US portfolio. Moreover, Phocas Financial Corp. has 0.55% invested in the company for 135,806 shares. The New York-based Clark Estates Inc Ny has invested 0.41% in the stock. Spark Investment Management Llc, a New York-based fund reported 43,000 shares.

Since January 1, 0001, it had 0 insider buys, and 14 insider sales for $22.17 million activity.

Among 2 analysts covering West Pharmaceutical Services (NYSE:WST), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. West Pharmaceutical Services had 5 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of West Pharmaceutical Services Inc. (NYSE:WST) has “Market Perform” rating given on Wednesday, September 21 by Wells Fargo. The firm has “Hold” rating given on Tuesday, August 4 by Zacks. The firm has “Buy” rating given on Friday, January 8 by Janney Capital. Wells Fargo initiated West Pharmaceutical Services Inc. (NYSE:WST) on Tuesday, March 22 with “Outperform” rating. On Friday, October 28 the stock rating was upgraded by Wells Fargo to “Outperform”.

Since May 2, 2017, it had 0 insider purchases, and 2 insider sales for $5.63 million activity. Malone Daniel also sold $384,816 worth of West Pharmaceutical Services Inc. (NYSE:WST) on Tuesday, May 2. FEDERICI WILLIAM J sold $5.25 million worth of stock.

Ruane Cunniff & Goldfarb Inc increased Builders Firstsource Inc (NASDAQ:BLDR) stake by 1.00 million shares to 5.01M valued at $54.93 million in 2016Q4. It also upped Dentsply Sirona Inc stake by 939,312 shares and now owns 9.10 million shares. Irsa Inversiones Y Rep S A (NYSE:IRS) was raised too.

Analysts await West Pharmaceutical Services Inc. (NYSE:WST) to report earnings on July, 27. They expect $0.65 EPS, up 10.17% or $0.06 from last year’s $0.59 per share. WST’s profit will be $47.67 million for 36.92 P/E if the $0.65 EPS becomes a reality. After $0.60 actual EPS reported by West Pharmaceutical Services Inc. for the previous quarter, Wall Street now forecasts 8.33% EPS growth.

Investors sentiment decreased to 0.96 in 2016 Q4. Its down 0.05, from 1.01 in 2016Q3. It fall, as 31 investors sold WST shares while 97 reduced holdings. 45 funds opened positions while 78 raised stakes. 66.40 million shares or 1.35% more from 65.52 million shares in 2016Q3 were reported. Winfield Associates has 0% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 30 shares. Checchi Advisers Lc holds 0.04% or 3,227 shares. Burt Wealth Advsrs reported 5 shares stake. Kistler has invested 3.02% in West Pharmaceutical Services Inc. (NYSE:WST). Schroder Investment Management Group accumulated 674,079 shares. Trexquant Investment LP holds 2,907 shares or 0.04% of its portfolio. Contravisory Investment Management has 0.06% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 2,117 shares. Private Advisor Group Inc Limited holds 2,808 shares or 0.01% of its portfolio. Strs Ohio has 0.06% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 155,000 shares. Geode Ltd Liability holds 516,115 shares. Great West Life Assurance Company Can reported 41,391 shares. Bnp Paribas Arbitrage Sa accumulated 21,273 shares. Victory Capital Management Inc reported 744,061 shares. Magee Thomson Inv Partners Lc has invested 4.12% in West Pharmaceutical Services Inc. (NYSE:WST). Prudential Financial reported 247,693 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: